An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis

Science

Volumn 326, Issue 5953, 2009, Pages 722-726

  Salahudeen, Ameen A ^a   Thompson, Joel W ^a   Ruiz, Julio C ^a   Ma, He Wen ^a   Kinch, Lisa N ^a   Li, Qiming ^a   Grishin, Nick V ^a   Bruick, Richard K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMERYTHRIN; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; OXYGEN; PROTEASOME; PROTEIN FBXL5; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

DEGRADATION; ENZYME ACTIVITY; GENE EXPRESSION; HOMEOSTASIS; IRON; LIGAND; MAMMAL; PROTEIN;

ARTICLE; HOMEOSTASIS; HUMAN; IRON DEPLETION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY;

CATALYTIC DOMAIN; CELL LINE; F-BOX PROTEINS; HELA CELLS; HEMERYTHRIN; HOMEOSTASIS; HUMANS; IRON; IRON REGULATORY PROTEIN 2; OXYGEN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

MAMMALIA;

EID: 70350576223     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1176326     Document Type: Article

References (28)

1. M. U. Muckenthaler, B. Galy, M. W. Hentze, Annu. Rev. Nutr. 28, 197 (2008).
2. M. L. Wallander, E. A. Leibold, R. S. Eisenstein, Biochim. Biophys. Acta 1763, 668 (2006).
3. E. Beutler, Annu. Rev. Med. 57, 331 (2006).
4. D. M. Wrighting, N. C. Andrews, Curr. Top. Dev. Biol. 82, 141 (2008).
5. M. W. Hentze, M. U. Muckenthaler, N. C. Andrews, Cell 117, 285 (2004).
6. T. A. Rouault, Nat. Chem. Biol. 2, 406 (2006).
7. D. M. Koeller et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3574 (1989).
8. B. Guo, J. D. Phillips, Y. Yu, E. A. Leibold, J. Biol. Chem. 270, 21645 (1995).
9. F. Samaniego, J. Chin, K. Iwai, T. A. Rouault, R. D. Klausner, J. Biol. Chem. 269, 30904 (1994).
10. K. Iwai et al., Proc. Natl. Acad. Sci. U.S.A. 95, 4924 (1998).
11. K. Yamanaka et al., Nat. Cell Biol. 5, 336 (2003).
12. E. Bourdon et al., Blood Cells Mol. Dis. 31, 247 (2003).
13. E. S. Hanson, M. L. Rawlins, E. A. Leibold, J. Biol Chem. 278, 40337 (2003).
14. J. Wang et. al., Mol. Cell. Biol. 24, 954 (2004).
15. K. B. Zumbrennen, E. S. Hanson, E. A. Leibold, Biochim. Biophys. Acta 1783, 246 (2008).
16. See supporting material on Science Online.
17. N. Zhang et al., Biochem. Biophys. Res. Commun. 359, 34 (2007).
18. A. R. Willems, M. Schwab, M. Tyers, Biochim. Biophys. Acta 1695, 133 (2004).
19. K. Iwai, R. D. Klausner, T. A. Rouault, EMBO J. 14, 5350 (1995).
20. S. L. Clarke et al., EMBO J. 25, 544 (2006).
21. C. Fillebeen, D. Chahine, A. Caltagirone, P. Segal, K. Pantopoulos, Mol. Cell. Biol. 23, 6973 (2003).
22. R. E. Stenkamp, Chem. Rev. 94, 715 (1994).
23. C. E. French, J. M. Bell, F. B. Ward, FEMS Microbiol. Lett. 279, 131 (2008).
24. J. H. Zhang, D. M. Kurtz Jr., Y. M. Xia, P. G. Debrunner, Biochemistry 30, 583 (1991).
25. N. J. Greenfield, Nat. Protocols 1, 2876 (2007).
26. J. M. Galan, M. Peter, Proc. Natl. Acad. Sci. U.S.A. 96, 9124 (1999).
27. D. E. Somers, S. Fujiwara, Trends Plant Sci. 14, 206 (2009).
28. 0-GST-Ubiquitin and helpful discussions; M. Brown and J. Goldstein for E2 expression constructs; K. Gardner and F. Correa for assistance with circular dichroism; the UTSW HTS facility for assistance with siRNA screening; and L. Wang, G. Pineda, S. Laxman, X. Du, and J. Wang for helpful discussions. R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by the Burroughs Wellcome Fund, the Robert A. Welch Foundation, the Texas Advanced Research Program, and NIH grant CA115962. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant C06 RR 15437-01) from the NIH National Center for Research Resources.